Strategic News Watch • July 17, 2026 Daily Biopharma Digest – July 17, 2026 July 17, 2026 Novartis won full FDA approval for Fabhalta in… Strategic News Watch Membership Required You must be a Strategic News Watch member to access this content. Join Now Already a member? Log in here Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription.